What a systematic review is, and what it is not
A systematic review is a structured way of finding, selecting, appraising and summarizing all the studies that address a defined question. Its defining features are that the question and methods are specified in advance, the search is comprehensive and documented so that it can be repeated, studies are chosen by explicit criteria, each study is assessed for risk of bias, and the synthesis and its limits are reported openly. These features protect against the selective use of evidence that makes an ordinary literature review unreliable.
A systematic review is not the same as a meta-analysis. The review is the process; the meta-analysis is an optional statistical step that combines the results when the studies are similar enough. Many systematic reviews include one, and many do not, either because only a few studies exist or because they differ too much in population, intervention or outcome. The distinction is explained in meta-analysis versus systematic review.
It is also not a quick summary. A well-conducted review is a research project in its own right, with a protocol, a team, a search, thousands of records to screen and a reproducible record of every decision. The value of the result comes from that discipline.
When a systematic review is the right design
The choice of review design should follow from the question, not from habit. A systematic review is appropriate when there is a focused question, a reasonable body of primary studies, and a need for a result that others can trust and repeat. The table compares the main alternatives.
| Aim | Design | Main consideration |
|---|---|---|
| Answer a focused question about effects, accuracy or association | Systematic review, with or without meta-analysis | Needs a comprehensive search and risk-of-bias appraisal |
| Map what evidence exists on a broad topic | Scoping review | Does not assess risk of bias or pool effects as a rule |
| Summarize several existing reviews | Umbrella review | Overlap of primary studies between reviews must be handled |
| Answer a time-limited decision | Rapid review | Shortcuts must be stated and their risks acknowledged |
| Understand experiences or meanings | Qualitative evidence synthesis | Uses different appraisal and synthesis methods |
| Give a general overview of a field | Narrative review | Not systematic, so more exposed to selection bias |
The scoping stage of a project is where this choice is made. It is better to reach the right design before the search than to discover afterwards that the review answers a different question from the one intended.
What the service includes
The service can cover the whole review or any part of it. The stages below are the usual components.
- Question and eligibility criteria framed in a structured way, with outcomes and study designs defined.
- Protocol and registration support, described under protocol development and registration.
- Search strategies for the databases and registries relevant to the field, with documentation. See search strategy development.
- Screening of titles, abstracts and full texts against the criteria, with a record of reasons for exclusion and the flow diagram.
- Data extraction onto a piloted form, as described under data extraction and coding.
- Risk-of-bias assessment with the tool that fits each design, and a GRADE assessment where relevant. See risk-of-bias and certainty assessment.
- Synthesis, including meta-analysis where it is justified, or a structured narrative synthesis where it is not.
- Reporting against PRISMA 2020, with the manuscript and submission support described under publication support.
Framing the question and the eligibility criteria
Everything in a review follows from the question, so the question deserves time. For intervention questions the usual frame is population, intervention, comparator and outcome (PICO), and variants such as PICOS add the study design. For other kinds of question, such as prognosis, exposure or qualitative experience, other frames fit better. The guide to PICO and related frameworks compares them.
The eligibility criteria turn the question into rules for deciding which studies count. They specify the population and setting, the interventions or exposures and comparators, the outcomes of interest and how they must have been measured, the study designs that will be accepted, and any limits on date, language or publication status. Each criterion should be justified, because each one can be challenged. Restricting to English-language publications, for example, is common and defensible in some topics and a source of bias in others.
Two problems recur. A question that is too broad produces an unmanageable number of studies that cannot be combined meaningfully, and a question that is too narrow may find nothing. The usual remedy is to refine the question against a scan of the literature before committing to a protocol, and to check whether a recent review already answers it.
Protocol and registration
A protocol records the review's question, criteria, search sources, screening and extraction procedures, risk-of-bias approach and synthesis plan before the results are known. Its purpose is to limit the freedom to change decisions in light of what the studies show, which is the main safeguard against selective reporting. The PRISMA-P guideline lists the items a protocol should contain.
Where a suitable registry exists, the protocol is registered. PROSPERO accepts systematic reviews with a health-related outcome, and other platforms are available for reviews outside its scope. Registration makes the plan public, allows readers to compare the published review with it, and helps to avoid duplication of effort. Changes after registration are recorded as amendments with the date and reason, and reported in the final paper.
Searching
The search is where many reviews are won or lost. A review that misses relevant studies has a problem that no later step can repair. A comprehensive search combines several bibliographic databases suited to the field, uses both controlled vocabulary and free-text terms for each concept in the question, and is supplemented by searching trial registries, reference lists of included studies and, where appropriate, grey literature such as theses, conference abstracts and reports. The strategy is tested against a set of studies already known to be relevant, and it is peer reviewed, ideally by a second searcher, using a checklist such as PRESS.
The search is documented in enough detail to be repeated: the databases and platforms, the dates searched, the full strategy for each, and the number of records retrieved. PRISMA-S sets out what to report. Because evidence accumulates, searches are updated before submission when a substantial time has passed. The topic is covered in the guide to building a search strategy and the guide to databases.
Screening and selection
Retrieved records are de-duplicated and then screened against the eligibility criteria, first by title and abstract and then by full text. Because screening involves judgment, it is normally done independently by two reviewers who resolve disagreements by discussion or by a third reviewer. Dual screening reduces the chance of excluding a relevant study by error, and where resources are limited a documented partial approach, such as a second reviewer checking a sample, can be used with its limits stated.
Every full-text exclusion is recorded with its reason, and the numbers at each stage feed the PRISMA flow diagram. One study can be reported in several papers, and several reports must be linked to a single study so that its data are counted once. The guide on de-duplication and screening describes the process in more detail.
Extraction and risk-of-bias assessment
Data are extracted onto a form that is piloted on a few studies before use. The form captures study characteristics, participants, interventions or exposures, outcome definitions, results and funding. Independent duplicate extraction, or at least independent verification of key data, is recommended because errors in extraction are common and can change conclusions. Where results are missing, they are sought from the full text, supplements and registry records and, where appropriate, from the authors.
Each included study is also assessed for risk of bias with a tool matched to its design, such as RoB 2 for randomized trials, ROBINS-I for non-randomized studies of interventions or QUADAS-2 for diagnostic accuracy. The judgments are used in the interpretation of the findings, in sensitivity analyses and in the rating of the certainty of the evidence. See risk-of-bias tools.
Synthesis
Synthesis combines the findings of the included studies. When the studies are sufficiently similar and report compatible data, a meta-analysis estimates an overall effect and examines differences between studies. When they are not, a structured narrative synthesis is the honest alternative. Narrative does not mean unstructured: the SWiM guideline describes how to group studies, to choose and report an effect measure, to present the results and to say how certain they are, without resorting to vote counting, which ignores the size and precision of each study.
In either case, the synthesis explores why results differ, using prespecified subgroups or study characteristics, and assesses the risk that the available evidence is distorted by publication bias or selective reporting. The certainty of the conclusions for each important outcome is then rated, for health questions usually with GRADE, and the conclusions are worded to match that certainty.
Reporting
PRISMA 2020 is the standard reporting guideline for systematic reviews. It consists of a checklist of 27 items covering the title, abstract, introduction, methods, results, discussion and other information, with a flow diagram of the study selection and a separate checklist for abstracts. Extensions exist for scoping reviews, diagnostic accuracy, network meta-analysis, individual participant data and literature searches. Journals increasingly ask for the completed checklist at submission.
Good reporting includes the full search strategies, the list of excluded full-text studies with reasons, the extracted data, the risk-of-bias judgments for each study, the code and the data used in any meta-analysis, and an account of every deviation from the protocol. The aim is that a reader could judge the review and, in principle, repeat it. See PRISMA 2020.
Deliverables
The package depends on the agreed scope. A complete review typically includes the following.
- Protocol and registration-ready summary.
- Search strategies for every source, with dates and record counts.
- Screening records and the PRISMA flow diagram.
- Extraction dataset and risk-of-bias assessments for each study.
- Synthesis, with figures and tables, and certainty ratings where relevant.
- Completed PRISMA checklist and the manuscript, where manuscript preparation is in scope.
Get a quoteDescribe your question, target journal and deadline.
Optional extension: full manuscript and submission
Full manuscript and submission package
When the scope includes writing up the review, the package also contains the following.
Full manuscript draft
Abstract, introduction, methods, results, discussion, tables and formatted references, written from the review.
PRISMA checklist and flow diagram
Completed against the final text, with the full search strategies as a supplement.
Submission package
A journal recommendation, the manuscript formatted to that journal, a cover letter and supplementary files.
Revision round
A point-by-point response to editor and reviewer comments, with re-analysis where requested.
Manuscript preparation follows the research integrity and authorship statement. The researchers who conceived the study and interpret its findings remain responsible for the content and its conclusions, and contributions that do not meet authorship criteria are acknowledged.
Quality assurance
- Prespecification. The protocol is fixed before screening, and deviations are logged with reasons.
- Independent checks. Screening, extraction and risk-of-bias judgments are performed or verified by a second person, as the protocol specifies.
- Documented decisions. Each exclusion, conversion and judgment is recorded so that it can be audited.
- Reproducible analysis. Code and settings are kept and delivered with the results.
- Confidentiality. Unpublished protocols and data are treated as confidential, as described in the research integrity statement.
Limitations of systematic reviews
A systematic review is only as reliable as the studies it summarizes and the completeness of the search that found them. No search is complete, and studies with null or unfavorable results are less likely to be published and found. Differences between studies in populations, interventions and outcome definitions can limit what can be combined, and the quality of the primary evidence caps the certainty of the conclusions however rigorous the review. Reviews also take time, so their conclusions may lag behind new studies, which is the motivation for living systematic reviews in fast-moving fields.
Many topics already have several reviews, some redundant or of low quality, so a new review needs a clear reason to exist. Finally, a review summarizes evidence and does not replace judgment: it does not tell an individual patient or a particular institution what to do.
This service provides research and evidence-synthesis support. It does not provide clinical advice, and the results of a review are not patient-specific guidance.
How long does a systematic review take?
The duration depends on the breadth of the question, the number of records to screen, the number of included studies, the number of outcomes, whether a meta-analysis is planned, and how quickly decisions are made. A narrow question with a few dozen included studies is a different project from a broad one with several hundred. After the scoping stage, a schedule is proposed with its dependencies, and any fixed deadline, such as a thesis submission or a grant report, is taken into account in the scope.
Frequently asked questions
What is the difference between a systematic review and a literature review?
A systematic review uses a prespecified protocol, a comprehensive documented search, explicit selection criteria and an assessment of risk of bias, so that it can be repeated. A literature review is usually less structured and more open to selective use of studies.
Do I have to include a meta-analysis in a systematic review?
No. A meta-analysis is included only when the studies are similar enough for a pooled estimate to be meaningful. Otherwise a structured narrative synthesis is reported, ideally following the SWiM guideline.
Should I register my systematic review?
Registration is strongly encouraged and often required by journals. PROSPERO accepts reviews with a health-related outcome, and other platforms can be used for reviews outside its scope. Check the current rules of the registry and of your target journal.
How many reviewers are needed for screening and extraction?
Two working independently is the usual standard for screening and, ideally, for extraction, because it reduces errors. Documented alternatives with stated limits are sometimes used when resources are restricted.
Can you update an existing systematic review?
Yes. An update repeats the search for the period since the last one, applies the original criteria, and integrates the new studies, with the methods and any changes reported clearly.
Does this service provide clinical advice?
No. It provides research and evidence-synthesis support. The results of a review are not advice about the care of an individual patient.
References
- Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
- Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.
- Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
- Rethlefsen ML, Kirtley S, Waffenschmidt S, et al. PRISMA-S: an extension to the PRISMA statement for reporting literature searches in systematic reviews. Syst Rev. 2021;10:39.
- Higgins JPT, Thomas J, Chandler J, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Cochrane; current version available at training.cochrane.org/handbook.
- McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-46.
- Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890.
- Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143.
- Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
- Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-926.
- Ioannidis JPA. The mass production of redundant, misleading, and conflicted systematic reviews and meta-analyses. Milbank Q. 2016;94(3):485-514.